Search

A recent study conducted by investigators from Akita University in Japan focused on the successful treatment of Monoclonal Immunotactoid Glomerulopathy associated with Chronic Lymphocytic Leukemia using Ibrutinib therapy. The study involved a 71-year-old woman who achieved complete renal remission after 24 months of treatment with Ibrutinib, a Bruton tyrosine kinase inhibitor. This research sheds light on a rare disease characterized by glomerular deposition and highlights the potential of Ibrutinib as a treatment option for this condition. [Extracted from the article]

A recent study conducted at Akita University Hospital in Japan developed a method using high-performance liquid chromatography with ultraviolet detection to measure venetoclax concentrations in plasma samples. The research validated the quantitative method according to standards set by the US Food and Drug Administration and successfully applied it to determine venetoclax concentrations in plasma of acute myeloid leukemia patients. The study concluded that this HPLC assay can help determine drug interactions between venetoclax and CYP3A4 inhibitors. For more information, readers can refer to the Journal of Chromatographic Science. [Extracted from the article]

Keywords for this news article include: Akita, Japan, Asia, Health and Medicine, Hormones, Hospitals, Parathyroid Hormone, Peptide Proteins, Risk and Prevention, Teriparatide, Akita University. Keywords: Akita; Japan; Asia; Health and Medicine; Hormones; Hospitals; Parathyroid Hormone; Peptide Proteins; Risk and Prevention; Teriparatide EN Akita Japan Asia Health and Medicine Hormones Hospitals Parathyroid Hormone Peptide Proteins Risk and Prevention Teriparatide 1779 1779 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on Peptide Proteins - Parathyroid Hormone have been presented. [Extracted from the article]